On July 15, 2025, Oppenheimer analyst Kristen Owen announced an adjustment in the price target for Nutrien (NTR, Financial), a leading company in the agribusiness sector. The firm's price target for NTR has been raised from $63.00 USD to $65.00 USD, marking a 3.17% increase. The adjustment reflects a positive outlook on the company's future performance.
Despite the increase in the price target, the rating for Nutrien (NTR, Financial) remains unchanged at "Outperform." This consistent rating suggests continued confidence in Nutrien's ability to surpass average market returns.
Investors and market observers will be keenly watching Nutrien (NTR, Financial) following this adjustment, as the analyst's positive sentiment may influence market perceptions and stock performance. As always, stakeholders are encouraged to consider a range of analyst opinions and insights before making investment decisions.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Nutrien Ltd (NTR, Financial) is $64.71 with a high estimate of $75.00 and a low estimate of $56.00. The average target implies an upside of 8.09% from the current price of $59.87. More detailed estimate data can be found on the Nutrien Ltd (NTR) Forecast page.
Based on the consensus recommendation from 23 brokerage firms, Nutrien Ltd's (NTR, Financial) average brokerage recommendation is currently 2.4, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Nutrien Ltd (NTR, Financial) in one year is $49.98, suggesting a downside of 16.52% from the current price of $59.87. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Nutrien Ltd (NTR) Summary page.
